Private Equity

Updated:

Hermed Capital

Hermed Capital is a private equity and venture capital firm that invests in the healthcare industry. Hermed Capital Fund (通德资本) is a private equity fund that...

Hermed Capital logo

Hermed Capital

Hermed Capital is a private equity and venture capital firm that invests in the healthcare industry. Hermed Capital Fund (通德资本) is a private equity fund that invests primarily in healthcare industry in China.

General information

Firm type

Private Equity Firm

Location

Region

Asia

Country

China

City

Shanghai

Corporate office

Shanghai, China

Frequently asked questions

What investment stages does Hermed Capital target?

Hermed Capital's investment mandate spans early-stage seed and start-up rounds through late-stage expansion and growth venture. The firm's public-facing strategy list includes general venture capital as well, indicating a willingness to evaluate companies across multiple financing stages.

Where is Hermed Capital based and does it invest outside China?

Hermed Capital operates from its headquarters in Shanghai, China. The firm's disclosed strategy focuses on Chinese private markets, and no public materials indicate a mandate to invest in other geographies.

Who runs investment decisions at Hermed Capital?

Hermed Capital has not publicly disclosed its investment committee composition or named principals. No team biographies appear on the firm's website or in publicly available regulatory filings.

Does Hermed Capital disclose its assets under management?

No. Hermed Capital does not publicly report an AUM figure. The firm maintains a low public profile with no disclosed fund closes or deployment aggregates, which is typical for a private equity manager that does not actively solicit institutional limited partners.

Is Hermed Capital affiliated with a larger corporate group or family office?

The firm's ownership and capital structure remain opaque in public record. Hermed Capital presents as an independent asset manager, but without disclosed partnership details, the exact nature of its backing — whether third-party institutional, family-linked, or otherwise — cannot be confirmed from available public sources.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Shanghai Private Equity Firm profiles